Picture of Clearside Biomedical, logo

CLSDQ — Clearside Biomedical, News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Clearside Biomedical Inc reports results for the quarter ended in June - Earnings Summary

* Clearside Biomedical Inc  CLSD.OQ  reported a quarterly
adjusted
loss of 10 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -15 cents.  The mean expectation of six analysts
for the quarter was for a loss of 13 cents per share. Wall
Street expected results to range from -16 cents to -12 cents per
share.
    * Revenue fell 91.2% to $90.00 thousand from a year ago;
analysts
expected $126.67 thousand. 
    * Clearside Biomedical Inc's reported EPS for the quarter
was a
loss of 10 cents​.
    * The company reported a quarterly loss of $7.59 million.
    * Clearside Biomedical Inc shares had fallen by 16.2% this
quarter and lost 6.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Clearside
Biomedical Inc is $5.00 
This summary was machine generated from LSEG data August 13 at
01:33 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       -0.13          -0.10          Beat
 Mar. 31 2024      -0.14          -0.15          Missed
 Dec. 31 2023      -0.09          -0.08          Beat
 Sep. 30 2023      -0.15          -0.15          Met

Recent news on Clearside Biomedical,

See all news